Literature DB >> 22314104

Does the relationship between natriuretic hormones and diastolic function differ by race?

Gaston K Kapuku1, Harry C Davis, Patrick Thomas, James Januzzi, Gregory A Harshfield.   

Abstract

INTRODUCTION: Heart failure develops earlier and is more prevalent in blacks than whites because of their higher incidence of hypertension and diabetes and likely subsequent diastolic dysfunction. Natriuretic peptides (NP) prevent cardiac malfunction through pressure, natriuresis action. However, whether race affects the relationships of NP action with cardiac function is unknown.
METHODS: To assess this, 55 (21 whites and 27 males) normotensive adults underwent a 2-hour protocol of 40 minutes rest, video game stressor and recovery. Mitral inflow and myocardial velocities (tissue Doppler) were recorded every 20 minutes. Blood pressure and heart rate were obtained at 10-minute intervals. Blood samples for pro-atrial NP and pro-brain NP (pro-BNP) were collected every 40 minutes.
RESULTS: There were differences in the association between (1) the changes from rest to stress for E/A ratio and double product (whites, r = -0.42; blacks, r = 0. 10; P = 0.034 for difference between correlations); (2) stress E(m) and pro-atrial NP (whites, r = 0.59; blacks, r = -0.25; P = 0.025); (3) rest E(m) and BNP (whites, r = 0.83; blacks r = -0.17; P = 000); (4) rest E(m)/A(m) and pro-BNP (whites, r = 0.70; blacks, r = -0.42; P = 0.003); (5) rest E/E(m) and pro-BNP (whites, r = -0.61; blacks, r = 0.31; P = 0.015) and (6) stress E and pro-BNP (whites, r = 0.56; blacks, r = -0.18; P = 0.043).
CONCLUSION: The higher correlations between levels of NP and diastolic function indices both at rest and stress suggest that NP protective action is more pronounced in whites than in blacks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22314104      PMCID: PMC3764598          DOI: 10.1097/MAJ.0b013e31823673fd

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  28 in total

1.  Cardiac output by impedance cardiography: two alternative methodologies compared with thermodilution.

Authors:  A Sherwood; L S Carter; C A Murphy
Journal:  Aviat Space Environ Med       Date:  1991-02

2.  Significance of brain natriuretic peptide measurement as a diagnostic indicator of cardiac function.

Authors:  S Waku; N Iida; T Ishihara
Journal:  Methods Inf Med       Date:  2000-08       Impact factor: 2.176

3.  Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload.

Authors:  Y Hirata; A Matsumoto; T Aoyagi; K Yamaoki; I Komuro; T Suzuki; T Ashida; T Sugiyama; Y Hada; I Kuwajima; M Nishinaga; H Akioka; O Nakajima; R Nagai; Y Yazaki
Journal:  Cardiovasc Res       Date:  2001-08-15       Impact factor: 10.787

4.  Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain.

Authors:  T Sudoh; N Minamino; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1988-09-15       Impact factor: 3.575

5.  Impaired left ventricular filling in borderline hypertensive patients without cardiac structural changes.

Authors:  G K Kapuku; S Seto; H Mori; M Mori; T Utsunomia; S Suzuki; Y Oku; K Yano; K Hashiba
Journal:  Am Heart J       Date:  1993-06       Impact factor: 4.749

6.  Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study.

Authors:  Alan S Maisel; Paul Clopton; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Gabriel Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Vikas Bhalla; Howard C Herrmann; Marie Claude Aumont; Peter A McCullough
Journal:  Am Heart J       Date:  2004-06       Impact factor: 4.749

7.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

8.  Does brain natriuretic peptide have a direct renal effect in human hypertensives?

Authors:  Kim van der Zander; Alphons J H M Houben; Abraham A Kroon; Thomas K A Wierema; Monique J M J Fuss-Lejeune; Derk Koster; Peter W de Leeuw
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

9.  Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; E Morita; N Sakaino; M Jougasaki; M Kurose; M Mukoyama; Y Saito; K Nakao; H Imura
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

10.  Blunted sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy. A possible compensatory role of atrial natriuretic factor.

Authors:  B Trimarco; G Lembo; N De Luca; M Volpe; B Ricciardelli; G Condorelli; G Rosiello; M Condorelli
Journal:  Circulation       Date:  1989-10       Impact factor: 29.690

View more
  2 in total

1.  Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Yuhree Kim; Kunihiro Matsushita; Yingying Sang; Morgan E Grams; Hicham Skali; Amil M Shah; Ron C Hoogeveen; Scott D Solomon; Christie M Ballantyne; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2014-10-23       Impact factor: 8.860

2.  Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Lori B Daniels; Paul Clopton; Christopher R deFilippi; Otto A Sanchez; Hossein Bahrami; Joao A C Lima; Russell P Tracy; David Siscovick; Alain G Bertoni; Philip Greenland; Mary Cushman; Alan S Maisel; Michael H Criqui
Journal:  Am Heart J       Date:  2015-09-28       Impact factor: 4.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.